Acerus Pharmaceuticals announced that it and its wholly-owned subsidiary, Acerus Pharmaceuticals USA, LLC entered into a US$2 million secured loan agreement with First Generation Capital Inc., a company affiliated with the Chairman of the Board of Directors of Acerus. Funds under the Loan Agreement will be made available to the Borrowers by way of.